Pharmacotherapy of obsessive compulsive disorder-experience with fluoxetine
The DOI matches its Crossref record.
Abstract
Recent epidemiological data have shown that obsessive compulsive disorder (OCD) has a lifetime prevalence of 2.5-3.0%. Compounds having an effect on serotonergic neurotransmission have demonstrated a reproducible therapeutic effect in OCD. Most recent attention has been focused on the specific serotonin re-uptake inhibitor (SSRI) class of compounds. The pooled data from two recently completed placebo-controlled studies of the SSRI, fluoxetine, have demonstrated clear evidence of a clinically valuable therapeutic effect in patients with OCD. Combined efficacy and safety data suggest that fluoxetine, 20 mg/day, will be effective in many patients. The therapeutic response emerges slowly and increases gradually. Data from extension studies suggest that, in some patients, an optimal response may only be achieved with higher daily doses of fluoxetine. Clinical response has been shown to be sustained over periods of 9 months of treatment and following withdrawal in an open-label trial. Fluoxetine is safe and well tolerated in this group of patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Wong, D. T., Bymaster, F. P., & Engleman, E. A. (1995) · Life Sciences · doi:10.1016/0024-3205(95)00209-o · Cited by 647
Saxena, S. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00082-2 · Cited by 379
“These criteria were chosen based on earlier use of these cutoffs for response in clinical studies (e.g., Montgomery et al. 1993; Wood et al. 1993; Koran et al. 1997).”
MethodResultCerebral glucose metabolism in obsessive-compulsive hoarding
Saxena, S., Brody, A. L., Maidment, K. M., Smith, E. C., Zohrabi, N., Katz, E., Baker, S. K., & Baxter, L. R. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.6.1038 · Cited by 343
Evidence-based pharmacotherapy of obsessive-compulsive disorder
Fineberg, N. A., Brown, A., Reghunandanan, S., & Pampaloni, I. (2012) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711001829 · Cited by 336
“A meta-analysis of the contemporaneous grouped data showed that the 60-mg dose was significantly more effective than 20 mg (Wood et al., 1993).”
MethodEfficacy of Drug Treatment in Obsessive–Compulsive Disorder: a Meta-Analytic Review
Piccinelli, M., Pini, S., Bellantuono, C., & Wilkinson, G. (1995) · British Journal of Psychiatry · doi:10.1192/bjp.166.4.424 · Cited by 282
Metadata
- Authors
- Wood, A., Tollefson, G. D., & Birkett, M.
- Venue
- International Clinical Psychopharmacology
- Published
- 1993
- Volume
- 8
- Issue
- 4
- Pages
- 301-306
- ISSN
- 0268-1315 (ISSN-L)
- OpenAlex
- W2091595086
- Cited by
- 35
- References
- 0
- FWCI
- 1.96
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pharmacotherapy of obsessive compulsive disorder-experience with fluoxetine. https://app.cochat.ai/papers/10.1097/00004850-199300840-00015
- The paper
- Wood, A., Tollefson, G. D., & Birkett, M. (1993). Pharmacotherapy of obsessive compulsive disorder-experience with fluoxetine. International Clinical Psychopharmacology. https://doi.org/10.1097/00004850-199300840-00015
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.